<code id='A9A8280873'></code><style id='A9A8280873'></style>
    • <acronym id='A9A8280873'></acronym>
      <center id='A9A8280873'><center id='A9A8280873'><tfoot id='A9A8280873'></tfoot></center><abbr id='A9A8280873'><dir id='A9A8280873'><tfoot id='A9A8280873'></tfoot><noframes id='A9A8280873'>

    • <optgroup id='A9A8280873'><strike id='A9A8280873'><sup id='A9A8280873'></sup></strike><code id='A9A8280873'></code></optgroup>
        1. <b id='A9A8280873'><label id='A9A8280873'><select id='A9A8280873'><dt id='A9A8280873'><span id='A9A8280873'></span></dt></select></label></b><u id='A9A8280873'></u>
          <i id='A9A8280873'><strike id='A9A8280873'><tt id='A9A8280873'><pre id='A9A8280873'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:88754
          light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece
          Pfizer CEO Albert Bourla was one of a few pharmaceutical executives who donated to a failed Senate campaign in New Jersey. Giannis Papanikos/AP

          You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

          Administration infighting over the national stockpile

          The health department’s preparedness office overseeing national stockpiles of emergency medical gear is trying to cement its Covid-era power — and meeting with congressional skepticism.

          advertisement

          The Administration for Strategic Preparedness and Response has seen demands for protective gear and therapies rapidly expand between the Covid-19 pandemic, the 2022 mpox outbreak, and now the spread of avian flu among cows. But its management of the nation’s medical stockpile — and its efforts to replenish depleting stock — are under fresh scrutiny from lawmakers. In particular, Republicans want answers on the $850 million that Congress clawed back from ASPR’s budget, and on why that cash wasn’t spent if the stockpile needed it so badly, my co-author Sarah Owermohle reports.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Listen: Who gets the credit for GLP
          Listen: Who gets the credit for GLP

          Whenisnegativedatapositiveenough?Whogetscreditforscientificbreakthroughs?Andwasn’tbiotechsupposedtob

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

          FILE-RichardMoore,theChiefofBritain'sSecretIntelligenceService,alsoknownasMI6,answersquestionsafterg